Firm News

Julie Cohen
Director of Marketing and Communications

Cahill Represents Debt Financing Sources for Bausch Health

Date: 11/29/18

Cahill represented the lead arrangers in connection with $1,500,000,000 incremental term loan facility for Bausch Health Companies Inc. Cahill also represented the dealer managers in connection with a tender offer to purchase any and all of Bausch Health Companies Inc.’s outstanding 7.500% Senior Notes due 2021. Bausch Health Companies Inc., formerly Valeant Pharmaceuticals International, Inc., is a multinational specialty pharmaceutical company. Proceeds from the loan will be used for general corporate purposes and to refinance existing indebtedness.